Callan Family Office LLC Buys Shares of 543 Mettler-Toledo International Inc. (NYSE:MTD)

Callan Family Office LLC bought a new stake in Mettler-Toledo International Inc. (NYSE:MTD) in the 4th quarter, HoldingsChannel.com reports. The institutional investor bought 543 shares of the medical instruments supplier’s stock, valued at approximately $664,000.

Several other institutional investors also recently bought and sold shares of the company. State Street Corp grew its position in Mettler-Toledo International by 1.0% in the 3rd quarter. State Street Corp now owns 954,653 shares of the medical instruments supplier’s stock valued at $1,431,693,000 after acquiring an additional 9,009 shares in the last quarter. Geode Capital Management LLC grew its position in Mettler-Toledo International by 0.8% in the 3rd quarter. Geode Capital Management LLC now owns 547,439 shares of the medical instruments supplier’s stock valued at $818,906,000 after acquiring an additional 4,166 shares in the last quarter. Principal Financial Group Inc. grew its position in Mettler-Toledo International by 13.9% in the 4th quarter. Principal Financial Group Inc. now owns 274,563 shares of the medical instruments supplier’s stock valued at $335,977,000 after acquiring an additional 33,456 shares in the last quarter. Barclays PLC grew its position in Mettler-Toledo International by 8.3% in the 3rd quarter. Barclays PLC now owns 256,602 shares of the medical instruments supplier’s stock valued at $384,822,000 after acquiring an additional 19,609 shares in the last quarter. Finally, JPMorgan Chase & Co. grew its position in Mettler-Toledo International by 14.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier’s stock valued at $332,634,000 after acquiring an additional 28,478 shares in the last quarter. 95.07% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Mettler-Toledo International

In other Mettler-Toledo International news, insider Gerry Keller sold 600 shares of the business’s stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $1,351.34, for a total value of $810,804.00. Following the completion of the sale, the insider now owns 6 shares in the company, valued at approximately $8,108.04. The trade was a 99.01 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Christian Magloth sold 790 shares of the business’s stock in a transaction that occurred on Monday, February 24th. The shares were sold at an average price of $1,313.69, for a total value of $1,037,815.10. Following the completion of the sale, the insider now owns 734 shares of the company’s stock, valued at approximately $964,248.46. This represents a 51.84 % decrease in their position. The disclosure for this sale can be found here. 1.94% of the stock is owned by company insiders.

Mettler-Toledo International Stock Up 1.6 %

Shares of MTD opened at $1,292.69 on Friday. The stock has a 50 day moving average price of $1,293.77 and a 200 day moving average price of $1,324.10. The company has a market capitalization of $27.04 billion, a price-to-earnings ratio of 31.89, a price-to-earnings-growth ratio of 3.30 and a beta of 1.15. Mettler-Toledo International Inc. has a 52-week low of $1,142.91 and a 52-week high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $11.76 by $0.65. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. On average, equities analysts anticipate that Mettler-Toledo International Inc. will post 42.71 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on the company. Citigroup lowered their price objective on Mettler-Toledo International from $1,450.00 to $1,400.00 and set a “neutral” rating for the company in a research report on Tuesday, March 4th. Evercore ISI boosted their price objective on Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the stock an “outperform” rating in a research report on Monday, February 10th. Wolfe Research assumed coverage on Mettler-Toledo International in a research report on Friday, December 13th. They set a “peer perform” rating for the company. Robert W. Baird boosted their price objective on Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the stock a “neutral” rating in a research report on Monday, February 10th. Finally, Stifel Nicolaus lowered their price objective on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a research report on Monday, November 11th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and three have assigned a buy rating to the company. According to MarketBeat, Mettler-Toledo International presently has an average rating of “Hold” and a consensus price target of $1,380.50.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.